BROADFIN CAPITAL, LLC Information

300 PARK AVENUE, 25TH FLOOR, NEW YORK, New York, 10022, (212) 808-2463

Report Date: 12/31/2015

Position Statistics

Total Positions 92
New Positions 9
Increased Positions 25
Decreased Positions 30
Positions with Activity 55
Sold Out Positions 11
Total Mkt Value (in $ millions) 1,080

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 1.46%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 75.09%
Services
Technology
Transportation
Utilities

30 DECREASED Positions as of 12/31/2015

Company Class Value of Shares ($1,000s) Change in Value ($1,000s) Change (%) Shares Held ▲
ACCURAY INC COM -4,020 Sold Out 0
BOVIE MEDICAL CORP COM -1,810 Sold Out 0
CARDIOVASCULAR SYS INC DEL COM -16,572 Sold Out 0
FLEXION THERAPEUTICS INC COM -3,478 Sold Out 0
HEARTWARE INTL INC COM -8,384 Sold Out 0
IRADIMED CORP COM -3,630 Sold Out 0
MASIMO CORP COM -17,940 Sold Out 0
ONCOTHYREON INC COM -782 Sold Out 0
SPECTRUM PHARMACEUTICALS INC COM -18,020 Sold Out 0
TETRAPHASE PHARMACEUTICALS INC COM -904 Sold Out 0
ZOSANO PHARMA CORP COM -792 Sold Out 0
MIRATI THERAPEUTICS INC COM 4,963 -1,259 (20.23) 235,870
VERACYTE INC COM 1,766 -2,497 (58.57) 304,980
ARDELYX INC COM 2,812 -1,610 (36.41) 349,290
RXI PHARMACEUTICALS CORP NEW COM 1,112 -217 (16.32) 512,648
SPECTRANETICS CORP COM 9,426 -5,591 (37.23) 565,079
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR 7,339 -38 (0.51) 583,121
DYNAVAX TECHNOLOGIES CORP COM NEW 11,039 -2,805 (20.26) 629,710
EMERGENT BIOSOLUTIONS INC COM 26,379 -37,197 (58.51) 672,922
KEMPHARM INC COM 12,128 -1,117 (8.43) 732,338